In a study recently published in Science Advances, Samir Mitragotri’s team at Harvard’s Wyss Institute engineered a new way to make one of the body’s own immune cells overcome a tumor’s defenses — the primary goal of immunotherapy. 

The immune cells are macrophages, quick-change artists that can flip from attack mode (good for battling attackers like cancer) to healing mode (good for promoting growth), depending on chemical cues in the microenvironment around them. Tumors secrete substances to switch macrophages into the latter mode, making them their allies in spreading cancer. But Mitragotri’s group found a way to thwart the tumors: The team strapped cellular “backpacks” filled with interferon-gamma on the macrophages. A cytokine, the interferon stimulates inflammation and keeps macrophages in attack mode. 

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy